{"hq_id":"hq-p-spe-000164","name":"PFAS in Drinking Water Beyond PFOA/PFOS (GenX, PFBS, PFHxS, EPA NPDWR 2024, 4 ppt MCL, Hazard Index, GAC/IX/RO Treatment)","category":{"primary":"specialty","secondary":"pfas_drinking_water","tags":["PFAS","PFOA","PFOS","GenX","HFPO-DA","PFBS","PFHxS","PFNA","drinking water","MCL","NPDWR","EPA","hazard index","granular activated carbon","ion exchange","reverse osmosis","tap water","USGS","water treatment","compliance 2029","forever chemicals"]},"product_tier":"SPE","overall_risk_level":"high","description":"Per- and polyfluoroalkyl substances (PFAS) in drinking water have moved beyond the legacy focus on PFOA and PFOS into a broader regulatory reckoning. The EPA finalized the first-ever PFAS National Primary Drinking Water Regulation (NPDWR) in April 2024, setting individual maximum contaminant levels (MCLs) of 4 parts per trillion (ppt) for PFOA and PFOS — the lowest MCLs ever established for any contaminant — and 10 ppt for PFHxS, PFNA, and HFPO-DA (GenX chemicals). Critically, the rule introduces a hazard index approach for mixtures of PFHxS, PFNA, HFPO-DA, and PFBS, recognizing that co-occurring PFAS act additively. A 2023 USGS nationwide study found detectable PFAS in 45% of US tap water samples, with higher prevalence near industrial sites, military bases (AFFF firefighting foam), and wastewater treatment outflows. The 10,000+ member PFAS family presents an enormous analytical challenge: only 6 compounds are now regulated, while thousands remain unmonitored. GenX (HFPO-DA), introduced as a PFOA replacement by Chemours, has contaminated drinking water in North Carolina's Cape Fear River basin at levels up to 600 ppt. PFBS, a short-chain PFAS once presumed safer, has a Reference Dose of 300 ng/kg/day (EPA 2021 toxicity assessment) reflecting thyroid, kidney, and developmental effects. Treatment technologies include granular activated carbon (GAC, 90-99% removal for long-chain PFAS, less effective for short-chain), anion exchange resins (IX, effective across chain lengths), and reverse osmosis (RO, 90%+ removal but generates concentrated reject water requiring management). The EPA allocated $1.2 billion through the Bipartisan Infrastructure Law for PFAS treatment in small and disadvantaged communities. Compliance deadline is 2029, requiring utilities to install monitoring and treatment systems within five years. Water utilities serving over 100 million Americans will likely need treatment upgrades.","synthesis":{"derived_risk_level":"moderate","synthesis_confidence":0.585,"synthesis_method":"compound_composition","context_used":"human_infant","context_source":"product_users","exposure_modifier":1,"vulnerability_escalated":true,"escalation_reason":"Infant exposure group","compounds_resolved":5,"compounds_total":5,"synthesis_date":"2026-05-09","synthesis_version":"1.2.0","methodology_note":"exposure_modifier and adjusted_magnitude are computed from ALETHEIA-calibrated heuristics (route × duration × frequency multipliers, clamped to [0.5, 1.4]). Multipliers are directionally informed by EPA Exposure Factors Handbook (2011) and CalEPA OEHHA but are not regulatory consensus. See /api/methodology for full disclosure."},"hazard_summary":{"sensitive_populations":"infants (formula-fed with contaminated water), pregnant women (PFAS crosses placenta), immunocompromised individuals (PFAS immunotoxicity), communities near military bases and industrial PFAS users, small water system customers lacking treatment resources","overall_risk":"high","primary_concerns":["PFOA and PFOS at 4 ppt MCL — lowest ever established, reflecting extreme toxicity at trace levels","10,000+ PFAS compounds but only 6 regulated — vast unmonitored exposure from unregulated congeners","45% of US tap water contains detectable PFAS (USGS 2023) — ubiquitous contamination","Short-chain replacements (GenX, PFBS) have their own toxicity profiles despite industry 'safer alternative' claims"],"exposure_routes":"Ingestion (primary: drinking water, cooking water, infant formula reconstitution). Inhalation (shower steam with volatile PFAS precursors). Dermal (bathing, though contribution minor compared to ingestion)"},"exposure":{"routes":["ingestion","inhalation","dermal"],"contact_types":["ingestion_direct","inhalation_incidental","dermal_contact"],"users":["general_population","child","infant"],"duration":"chronic","frequency":"continuous","scenarios":["Municipal water consumer: daily ingestion of 2L tap water containing multiple PFAS at low-ppt levels","Infant formula preparation: reconstitution with PFAS-contaminated tap water concentrates exposure per body weight","Household cooking: boiling does not remove PFAS — concentrates non-volatile PFAS as water evaporates","Showering and bathing: dermal and inhalation exposure to volatile and semi-volatile PFAS precursors"],"notes":"EPA NPDWR (April 2024): first federal PFAS drinking water regulation. MCLs: PFOA 4 ppt, PFOS 4 ppt, PFHxS 10 ppt, PFNA 10 ppt, HFPO-DA 10 ppt. Hazard index for mixtures of PFHxS, PFNA, HFPO-DA, PFBS (set at 1.0). MCLG (goal): zero for PFOA and PFOS. Compliance deadline: 2029. USGS (2023, Environment International): 45% of US tap water had at least one detectable PFAS. Military bases: DOD identified 700+ installations with known or suspected PFAS releases from AFFF. Treatment: GAC bed life 6-18 months depending on PFAS concentration and co-contaminants. IX resins: single-use or regenerable; highly effective for short-chain PFAS where GAC underperforms. RO: 90%+ removal but high energy cost and concentrate management challenge. Cost: EPA estimates $1.5 billion/year compliance cost for all US water systems. Small systems (<10,000 people) face disproportionate per-capita costs. Bipartisan Infrastructure Law: $9 billion for PFAS remediation and treatment, $1.2 billion specifically for small/disadvantaged communities."},"consumer_guidance":{"usage_warning":"Test your drinking water for PFAS using an EPA-certified laboratory (EPA Method 533 or 537.1). Request your water utility's most recent PFAS monitoring results — public systems must begin monitoring under the 2024 NPDWR. If PFAS are detected above MCLs, use a point-of-use reverse osmosis system (NSF/ANSI 58 certified for PFAS reduction) or a whole-house GAC system. Do not rely on standard carbon pitcher filters for complete PFAS removal — only NSF P473-certified filters demonstrate adequate reduction. Boiling water does NOT remove PFAS and may increase concentration.","safer_alternatives":["NSF P473 or NSF 53-certified point-of-use filters specifically tested for PFAS removal","Reverse osmosis under-sink systems (90%+ PFAS removal across chain lengths)","Whole-house granular activated carbon systems with regular media replacement","Bottled water from verified PFAS-free sources as interim measure during treatment installation"]},"regulatory":{"applicable_regulations":[{"jurisdiction":"USA","regulation":"EPA PFAS National Primary Drinking Water Regulation (NPDWR) — Final Rule April 2024","citation":"89 FR 32532 (April 26, 2024); 40 CFR 141 and 142; Safe Drinking Water Act Section 1412","requirements":"MCLs: PFOA 4 ppt, PFOS 4 ppt, PFHxS 10 ppt, PFNA 10 ppt, HFPO-DA 10 ppt. Hazard index of 1.0 for mixtures of PFHxS, PFNA, HFPO-DA, PFBS. MCLGs: zero for PFOA and PFOS; 10 ppt for PFHxS, PFNA, HFPO-DA. Initial monitoring within 3 years of promulgation. Compliance (install treatment) within 5 years (2029). Applies to all public water systems. Analytical methods: EPA 533, 537.1. Quarterly monitoring until compliance demonstrated. State primacy agencies enforce.","compliance_status":null,"effective_date":"2024-04-26","enforcing_agency":"EPA / State drinking water programs","penalties":null,"source_ref":null}],"certifications":[],"labeling":{"required_disclosures":[],"prop65_warning":{"required":null,"chemicals":[],"endpoint":null,"notes":null},"ghs_labeling":{"required":null,"signal_word":null,"pictograms":[],"hazard_statements":[],"notes":null},"hidden_ingredients":{"trade_secret_protected":null,"categories_hidden":[],"estimated_count":null,"known_concerns":null,"notes":null},"notes":null},"recalls":[],"regulatory_gap":null,"notes":null},"lifecycle":{"recyclable":false,"disposal_guidance":"Spent GAC and IX resin from PFAS treatment require thermal destruction (incineration at >1,100 degrees C) or landfill disposal in lined facilities. RO concentrate containing concentrated PFAS requires permitted disposal — direct discharge to surface water is prohibited without PFAS treatment.","hazardous_waste":false,"expected_lifespan":"Continuous exposure via drinking water supply; PFAS environmental persistence measured in decades to centuries"},"formulation":{"form":"varies","key_ingredients":[],"certifications":[]},"materials":{"common":[],"concerning":[],"preferred":[]},"compound_composition":[{"hq_id":"hq-c-mix-000018","compound_name":null,"role":"contaminant_class","typical_concentration":"10,000+ PFAS compounds; 45% of US tap water has detectable PFAS (USGS 2023); only 6 compounds regulated"},{"hq_id":"hq-c-org-000020","compound_name":null,"role":"legacy_contaminant","typical_concentration":"MCL 4 ppt individual; detected in >99% of NHANES blood samples; serum half-life 2-4 years"},{"hq_id":"hq-c-org-000091","compound_name":null,"role":"legacy_contaminant","typical_concentration":"MCL 4 ppt individual; bioaccumulative; serum half-life 4-6 years; Stockholm Convention listed 2009"},{"hq_id":"hq-c-org-000123","compound_name":null,"role":"replacement_contaminant","typical_concentration":"MCL 10 ppt; Cape Fear River NC contamination up to 600 ppt; shorter half-life but persistent"},{"hq_id":"hq-c-org-000124","compound_name":null,"role":"short_chain_pfas","typical_concentration":"hazard index component; EPA Reference Dose 300 ng/kg/day; thyroid and developmental effects"}],"identifiers":{"common_names":["pfas in drinking water beyond pfoa/pfos (genx, pfbs, pfhxs, epa npdwr 2024, 4 ppt mcl, hazard index, gac/ix/ro treatment)"],"aliases":[],"manufacturer":null,"brands":[]},"brand_examples":[{"brand":"3M","manufacturer":"3M","market_position":"mass_market","notable":"Safety and specialty product conglomerate"},{"brand":"Honeywell","manufacturer":"Honeywell","market_position":"mass_market","notable":"Safety equipment and technology"},{"brand":"DuPont","manufacturer":"DuPont","market_position":"professional","notable":"Chemical and safety products"}],"brand_examples_disclaimer":"Representative branded products of this category. Concerning ingredients listed in materials.concerning[] apply to the category, not necessarily to every named brand. Specific formulations vary by SKU and may have changed since this record was written; consult the brand's current ingredient label before drawing brand-level conclusions.","sources":[{"type":"expert_curation","name":"ALETHEIA Safety Database","date":"2026-03-26"},{"type":"regulation","title":"EPA PFAS National Primary Drinking Water Regulation (NPDWR) — Final Rule April 2024 (89 FR 32532 (April 26, 2024); 40 CFR 141 and 142; Safe Drinking Water Act Section 1412)","jurisdiction":"USA","year":2024,"citation":"89 FR 32532 (April 26, 2024); 40 CFR 141 and 142; Safe Drinking Water Act Section 1412","id":"src_24022484"},{"id":"epa_pfas_mcl_2024","type":"regulatory","title":"US EPA: National Primary Drinking Water Regulations for PFAS — Final Rule (April 2024): Individual MCLs for PFOA/PFOS (4 ppt), PFNA/PFHxS/HFPO-DA (10 ppt), and Hazard Index for PFAS Mixtures","year":2024,"inherited_from_compound":"hq-c-mix-000018"},{"id":"iarc_135_pfas","type":"regulatory","title":"IARC Monographs Volume 135: Perfluorooctanoic Acid and Its Salts and Other Per- and Polyfluoroalkyl Substances — PFAS Carcinogenicity Framework, Group 1 Evidence, and Regulatory Context (2023)","year":2023,"inherited_from_compound":"hq-c-mix-000018"},{"id":"iarc_135","type":"regulatory","title":"IARC Monographs Volume 135: Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonic Acid (PFOS)","year":2023,"inherited_from_compound":"hq-c-org-000020"},{"id":"epa_pfoa_2024","type":"regulatory","title":"US EPA: PFAS National Primary Drinking Water Regulation; PFOA MCL 4 ppt, MCLG zero","year":2024,"inherited_from_compound":"hq-c-org-000020"},{"id":"iarc_2a_pfos_2023","type":"regulatory","title":"IARC Monographs Volume 135: Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonic Acid (PFOS) — Group 2A Evaluation (Probably Carcinogenic to Humans)","year":2023,"inherited_from_compound":"hq-c-org-000091"},{"id":"epa_pfas_mclg_2024","type":"regulatory","title":"US EPA: National Primary Drinking Water Regulation for PFAS — Maximum Contaminant Level Goals and MCLs for PFOA, PFOS, and Four Other PFAS (Final Rule)","year":2024,"inherited_from_compound":"hq-c-org-000091"},{"id":"epa_hfpo_da_health_effects","type":"regulatory","title":"US EPA: Human Health Toxicity Values for Hexafluoropropylene Oxide (HFPO) Dimer Acid and Its Ammonium Salt (GenX Chemicals) — Kidney, Liver, Developmental Toxicity; Oral and Inhalation Reference Values","year":2021,"inherited_from_compound":"hq-c-org-000123"},{"id":"epa_pfbs_tox_review","type":"regulatory","title":"US EPA: Toxicological Review of Perfluorobutane Sulfonate (PFBS) — Thyroid Effects, Reference Dose (0.0003 mg/kg/day), and Hazard Index Grouping with Other Short-Chain PFAS","year":2021,"inherited_from_compound":"hq-c-org-000124"},{"type":"regulatory","title":"US Environmental Protection Agency (EPA)","jurisdiction":"USA","id":"src_defdd418","extraction":"description_reference"}],"meta":{"schema_version":"4.0.0","last_updated":"2026-03-26","timestamp":"2026-05-14T01:22:39.450Z"}}